Ethicon Endo-Surgery Inc recalls SEDASYS Computer-Assisted Personalized Sedation System, SEDPRU01. An integrated physiological monitoring and drug deliv…
- Recall date
- May 13, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2374-2015
- FDA classification
- Class I
- Brand / firm
- Ethicon Endo-Surgery Inc
- Sold / distributed
- Nationwide Distribution including OH, RI, TX & WA.
Why it was recalled
Ethicon has found that disinfecting methods not specified in the Instructions For Use (IFU) have led to the degradation of the plastic material of the SEDASYS System Control Unit.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
SEDASYS Computer-Assisted Personalized Sedation System, SEDPRU01. An integrated physiological monitoring and drug delivery system intended to provide physician-led teams with a means of administering 1% propofol (10 mg/mL) injectable emulsion to sedate patients > 18 (ASA I-II) undergoing esophagogastroduodenoscopy (EGD) and colonoscopy procedures. Intended to provide physician-led teams with a means of administering 1% propofol (10 mg/mL) injectable emulsion to sedate patients > 18 (ASA I-II) undergoing esophagogastroduodenoscopy (EGD) and colonoscopy procedures.
Get recall alerts
Free email alert whenever Ethicon Endo-Surgery Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Ethicon Endo-Surgery Inc